Delivery Order SPE2DB24D1201-SPE2DB24FJAZU

Award Date 8/19/24
Potential Completion Date 8/20/24
Potential Value $3.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,779.78 firm fixed-price delivery order is for the supply of 500 capsules of Ramipril 10 mg, a medication used to treat high blood pressure and heart failure. The award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999...
This $7,661.05 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of 4,565,786,561 Ramipril 5 mg capsules, which are prescribed for the treatment of high blood pressure and heart failure. The delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999, that allows the agency to efficiently procure a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,990.40 firm fixed-price delivery order is for the supply of 4,558,265,410 capsules of 10 mg Ramipril, a medication used to treat high blood pressure and heart failure. The contract has an ultimate completion date of August 30, 2022 and was awarded on August 29, 2022. This award is associated with a larger...
This federal contract award, valued at $9,136.39, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ramipril 10 mg capsules, a medication used to treat high blood pressure and heart failure. The contract has a firm fixed-price pricing type and an ultimate completion date of November 15, 2023. It is not designated as a set-aside contract. Amerisourcebergen...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ramipril 10 mg capsules. The $4,008.89 firm fixed-price contract has an ultimate completion date of August 8, 2024. This delivery order is under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision...
This federal contract award, valued at $12,976.85, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Ramipril 10 mg capsules, a medication used to treat high blood pressure and heart failure. The contract has an ultimate completion date of March 8, 2024 and is a Firm Fixed Price arrangement. Amerisourcebergen holds a significant Indefinite...
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical sourcing and distribution company Amerisourcebergen Corporation. The $1,183.52 contract is for the delivery of 4,564,210,695 units of the medication Ramipril 2.5 mg capsules. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp, with a...
This federal contract award (SPE2DB20D3103|SPE2DB21FP9Q9) was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4554485446 - Ramipril 5 mg capsules in 500-count quantities. The contract has a ceiling value of $4,319.43 and an ultimate completion date of August 20, 2021. The award was made on a firm fixed-price basis with no set-aside designation, indicating open competition....
This federal contract award is for the delivery of 500 capsules of the prescription drug Ramipril 10 mg, valued at $1,949.35. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a component of the Department of Defense. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical....
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, for the supply of 10 mg ramipril capsules. The $3,693.84 order was not set aside for any specific business category. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of...
  • SPE2DB24D1201
    Indefinite Delivery Contract
  • SPE2DB24D1201-SPE2DB24FJAZU
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor in the United States. The $3,667.29 firm fixed-price delivery order is for the supply of 100 count capsules of Ramipril 5 mg, a medication used to treat high blood pressure.

The award was made under an Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide.

There was no set-aside designation for this award. The contract has an ultimate completion date of August 20, 2024.

Generated 11/18/24, 9:20 AM